PEGSTIM injection is a brand-name prescription medication containing Pegfilgrastim, which is a colony-stimulating factor used to help the body produced more white blood cells and lower the risk of severe infections during chemotherapy. It prevents chemotherapy-induced neutropenia by stimulating the bone marrow to rapidly produce neutrophils, a vital type of white blood cell needed to fight infections.

WHAT IS PEGSTIM INJECTION PFS?

PEGSTIM 6mg injection PFS is classified as a granulocyte colony-stimulating factor (G-CSF) hematopoietic agent.

Key classification:

• Drug class: colony-stimulating factor/hematopoietic agent
• Active ingredient: Pegfilgrastim (6mg/0.6ml)
• Dosage form: PFS (pre-filled syringe ) for subcutaneous injection
• Primary use: prevents severe neutropenia and infection risk in

Patients undergoing myelosuppressive chemotherapy for non-myeloid cancers.

• Role in preventing chemotherapy –induced neutropenia: A PFS delivers a long-acting growth factor that stimulates the bone marrow to quickly make new white blood cells, preventing dangerous drops in neutrophils caused by myelosuppressive chemotherapy.
• Mechanism of action: it prompts the bone marrow to produce, mature and release infection-fighting white blood cells (neutrophils ).

WHAT ARE THE USES OF PEGSTIM INJECTION?

Uses of PEGSTIM injection are:

1)Prevention of febrile neutropenia associated with chemotherapy

PEGSTIM injection is a long-acting colony –stimulating factor used once per chemotherapy cycle to prevent severe neutropenia and the risk of infection . it is a pegglated form of stimulating factor that stimulates the bone marrow to rapidly produce new neutrophils . Due to its larger molecular size, it stays in the body longer and clears out as neutrophil count recover, requiring only a single dose cycle instead of daily injections.

2)Reduction in the duration of chemotherapy-induced neutropenia

A single injection of PEGSTIM per chemotherapy cycle significantly reduces the duration of severe neutropenia and lowers the risk of febrile neutropenia compared to daily injections. A polyethylene glycol molecule is attached to filgrastim, which prevents rapid clearance by the kidneys . The drug stays in the blood and is cleared by the neutrophils, it decreases naturally as once neutrophils count recovers . one 6 mg injection per chemotherapy cycle replaces 10 to 11 daily injections of standard filgrastim.

3)Support of neutrophil recovery during appropriate cancer treatment

A PEGSTIM injection stimulates the bone marrow to produce infection-fighting ,white blood cells , specifically during cancer chemotherapy. It act like a natural growth factor (G-CSF) to help the body recover from low white blood cell count. It also prevents serious condition called febrile neutropenia it helps keep the chemotherapy on track without unnecessary dose delays.

4)Use according to oncologist treatment plan

PEGSTIM injection is used to prevent severe infections by helping the bone marrow make new white blood cells after myleosuppressive chemotherapy. Cancer drugs lower once count of neutrophils ,this medicine also lowers one risk of feer and dangerous infections. It is a lab-made protein that signals one bone marrow to produce white blood cells quickly. Usually given as a single 6 mg injection under the skin per chemotherapy cycle.

HOW PEGSTIM WORK?

PEGSTIM works by telling the bone marrow to make more white blood cells, specially neutrophils ,which protect the body from infections.

It works in the body in the following ways:

• Stimulation of the G-CSF receptor

PEGSTIM stimulates the granulocyte colony-stimulating factor (G-CSF) receptor by binding directly to it through its protein component , which triggers cell growth and maturation signals in the bone marrow . the active protein part of PEGSTIM attaches to the specific G-CSF receptors located on the surface of immature blood cells . this binding turns on the inside of the cell , specifically activating  JAK-STAT pathway . the cell signal tell the bone marrow to multiply these progenitor cells and turn them into mature infection-fighting white blood cells called neutrophils.

• Promotion of neutrophil production in the bone marrow

PEGSTIM promotes neutrophil production by acting as a long-acting artificial version of a natural growth factor that signals the bone marrow to manufacture infection-fighting white blood cells . the drug travels through the bloodstream to the bone marrow and bid to specific G-CSF receptors on the surface of immature precursor cells . This binding activates internal cell pathways that tell the immature cells to grow, divide and survive . it accerlates the transformations of stem cells into mature neutrophils and promotes the bone marrow to release them rapidly into the blood stream.

• Increase in circulating neutrophil levels

PEGSTIM increases circulating neutrophil levels by binding to a specific receptors on bone marrow cells to stimulate their production ,maturation and release. It attaches to G-CSF on hematopoietic stem cells and myeloid precursor cells. It also triggers the rapid proliferation of neutrophil precursors cells in the bone marrow. It pushes the newely formed mature neutrophils out of the bone marrow and into the bloodstream. It also prolongs the lifespan of mature neutrophils by preventing their early cell death.

• Long-acting effect compared with filgrastim

PEGSTIM requires only a single injection per chemotherapy cycle , whereas filgratism requires daily injections upto 14 days. PEGSTIM is cleared rapidly by the kidneys. Both drugs offered a similar overall ability to reduce severe neutropenia .

WHAT ARE THE BENEFITS OF PEGSTIM?

Benefits of PEGSTIM are :

• Helps reduce the risk of chemotherapy- related neutropenia

PEGSTIM lowers the chance of febrile neutropenia by stimulating the body to make infection-fighting white blood cells called neutrophils. It act like a natural body signal to help bone marrow quickly produce neutrophils after harsh chemotherapy. Patient usually need only one injection per chemotherapy cycle instead of many doses.

2)Helps lower the risk of febrile neutropenia

PEGSTIM reduces the risk of febrile neutropenia by stimulating the bone marrow to produce infection-fighting white blood cells called neutrophils during cancer chemotherapy. It is a pegylated form of filgrastim that stays in the body longer, meaning it usually requires only a single injection per chemotherapy cycle. It significantly cut down the rate of neutropenia , hospital stays and infection-related deaths.

CONCLUSION

PEGSTIM act as a long-acting bone marrow stimulus that effectively decreases the duration of severe chemotherapyhttps://oncomshealthcare.com/living-with-prostate-cancer-treatment-diet-lifestyle-tips/comprehensive-guide-to-chemotherapy-and-cancer-care/ –induced neutropenia with a single injection per cycle. Its self-regulating clearance and predictable safety profile maintain cancer treatment intensity without neccessiting daily dosing. If effectively manages severe neutropenia and reduces febrile neutropenia risk through a single dose subcutaneous administration per chemotherapy cycle. Its self -regulating clearance profile and safety comparibilty to short-acting filgrastism offer a dependable alternative that eliminates multiple daily administrations.

FREQUENTLY ASKED QUESTIONS (FAQs) :

QUESTION: WHAT IS PEGSTIM INJECTION USED FOR?

PEGSTIM injection is used to lower the risk of severe infections in cancer patients receving chemotherapy  by stimulating bone marrow to produce more white blood cells.it treats and prevents neutropenia caused by non-myeloid cancer medicines. This help reduce infection risk and prevents delay in chemotherapy schedule. It is also used to improved survival in patient who have been exposed to myelosuppressive doses of radiation .

QUESTION: HOW DOES PEGFILFGRASTIM WORK?

Pegfilgrastim work by signaling the bone marrow to quickly make more neutrophils , which are white blood cells that fight infections. It is a manmade version of a natural protein one body makes called granuloyte colony –stimulating factor (G-CSF). It attaches ti immature cells in the bone marrow and triggers them to grow and mature into infection fighting neutrophils.

QUESTION: WHY CAN PEGSTIM CAUSE BONE PAIN?

PEGSTIM frequently causes bone pain because it rapidly stimulates the bone marrow to produce new white blood cells. It happens because the medicine stimulates one bone marrow to quickly make new white blood cells. Pain typically effects areas with high bone marrow activity, such as lower back pain,pelvis,  sternum and long bones .

REFRENCES:

1)https://www.1mg.com/drugs/pegstim-injection-110988?wpsrc=Google+Organic+Search

2)https://m.indiamart.com/proddetail/pegstim-6mg-pegfilgrastim-injection-26035051412.html